|
| Status |
Public on Feb 19, 2019 |
| Title |
Effect of BB608 on STAT3 DNA Binding in HNSCC Cell Line |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
Study to determine the genome wide effects on STAT3 binding in FaDu cells treated with BB608, a transcription factor inhibitor.
|
| |
|
| Overall design |
2 samples DMSO treated, ChIP using STAT1 or STAT3 antibody. 2 samples BB608 treated, ChIP using STAT1 or STAT3 antibody
|
| |
|
| Contributor(s) |
Ao Y, Harry R, Chen Z, Xiangao S, Chiang L |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| |
| Submission date |
Feb 23, 2016 |
| Last update date |
May 15, 2019 |
| Contact name |
Harry Rogoff |
| Organization name |
Boston Biomedical, Inc.
|
| Street address |
640 Memorial Dr.
|
| City |
Cambridge |
| State/province |
MA |
| ZIP/Postal code |
02139 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
| Samples (5)
|
|
| Relations |
| BioProject |
PRJNA312943 |
| SRA |
SRP070705 |
Less...
More...